ATE348167T1 - Kleines säurelösliches sporenprotein und seine verwendungen - Google Patents

Kleines säurelösliches sporenprotein und seine verwendungen

Info

Publication number
ATE348167T1
ATE348167T1 AT01996611T AT01996611T ATE348167T1 AT E348167 T1 ATE348167 T1 AT E348167T1 AT 01996611 T AT01996611 T AT 01996611T AT 01996611 T AT01996611 T AT 01996611T AT E348167 T1 ATE348167 T1 AT E348167T1
Authority
AT
Austria
Prior art keywords
spor
protein
acid soluble
small acid
small
Prior art date
Application number
AT01996611T
Other languages
English (en)
Inventor
Heather Marie Fairhead
Original Assignee
Phico Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phico Therapeutics Ltd filed Critical Phico Therapeutics Ltd
Application granted granted Critical
Publication of ATE348167T1 publication Critical patent/ATE348167T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pest Control & Pesticides (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Dentistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
AT01996611T 2000-11-17 2001-11-16 Kleines säurelösliches sporenprotein und seine verwendungen ATE348167T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0028130.3A GB0028130D0 (en) 2000-11-17 2000-11-17 Polypeptide and uses thereof

Publications (1)

Publication Number Publication Date
ATE348167T1 true ATE348167T1 (de) 2007-01-15

Family

ID=9903398

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01996611T ATE348167T1 (de) 2000-11-17 2001-11-16 Kleines säurelösliches sporenprotein und seine verwendungen

Country Status (12)

Country Link
US (2) US7632512B2 (de)
EP (1) EP1343896B1 (de)
JP (1) JP4225780B2 (de)
AT (1) ATE348167T1 (de)
AU (2) AU2002223814B2 (de)
CA (1) CA2428662C (de)
DE (1) DE60125232T2 (de)
DK (1) DK1343896T3 (de)
ES (1) ES2276856T3 (de)
GB (1) GB0028130D0 (de)
PT (1) PT1343896E (de)
WO (1) WO2002040678A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0314469D0 (en) * 2003-06-20 2003-07-23 Phico Therapeutics Ltd Antimicrobial compositions and uses thereof
US7674621B2 (en) * 2004-05-21 2010-03-09 The United States Of America As Represented By The Department Of Health And Human Services Plasmids and phages for homologous recombination and methods of use
FR2910492B1 (fr) * 2006-12-20 2013-02-15 Bio Modeling Systems Ou Bmsystems Procede de preparation de bacteriophages modifies par insertion de sequences aleatoires dans les proteines de ciblage desdits bacteriophages
GB0715416D0 (en) * 2007-08-07 2007-09-19 Phico Therapeutics Ltd Modified bacteriophage
GB201417808D0 (en) 2014-10-08 2014-11-19 Phico Therapeutics Ltd Modified bacteriophage
GB201417810D0 (en) 2014-10-08 2014-11-19 Phico Therapeutics Ltd Modifying bacteriophage
GB201417811D0 (en) * 2014-10-08 2014-11-19 Phico Therapeutics Ltd Modifying bacteriophage
GB201417805D0 (en) * 2014-10-08 2014-11-19 Phico Therapeutics Ltd Modifield bacteriophage
EP3440204A1 (de) 2016-04-08 2019-02-13 Phico Therapeutics Ltd Modifizierung von bakteriophagen
PT3440200T (pt) * 2016-04-08 2021-04-30 Phico Therapeutics Ltd Bacteriófago modificado
US20220175827A1 (en) * 2019-04-05 2022-06-09 Northeastern University Biosynthesis of Selenium Nanoparticles Having Antimicrobial Activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09511397A (ja) * 1994-04-05 1997-11-18 エクスポネンシャル バイオセラピーズ,インコーポレイテッド 遺伝子型改変バクテリオファージによる抗菌治療
CA2329908A1 (en) * 1998-04-24 1999-11-04 The Regents Of The University Of California Targeted gene delivery to cells by filamentous bacteriophage
CA2334043A1 (en) * 1998-07-10 2000-01-20 Loyola University Of Chicago Antibiotic protein and method of production
AU2001229342A1 (en) 2000-01-11 2001-07-24 Intralytix, Inc. Method for produce sanitation using bacteriophages

Also Published As

Publication number Publication date
DE60125232T2 (de) 2007-05-31
US7632512B2 (en) 2009-12-15
CA2428662A1 (en) 2002-05-23
JP2004513647A (ja) 2004-05-13
JP4225780B2 (ja) 2009-02-18
ES2276856T3 (es) 2007-07-01
AU2381402A (en) 2002-05-27
DK1343896T3 (da) 2007-04-10
AU2002223814B2 (en) 2007-08-30
US20100209393A1 (en) 2010-08-19
DE60125232D1 (de) 2007-01-25
CA2428662C (en) 2010-10-05
GB0028130D0 (en) 2001-01-03
US20040097705A1 (en) 2004-05-20
WO2002040678A1 (en) 2002-05-23
US8133498B2 (en) 2012-03-13
EP1343896A1 (de) 2003-09-17
PT1343896E (pt) 2007-02-28
EP1343896B1 (de) 2006-12-13

Similar Documents

Publication Publication Date Title
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
ATE323488T1 (de) Nitratsalze von antimikrobiellen wirkstoffen
NL1015859A1 (nl) Farmaceutische preparaten.
BR0209242A (pt) Aminopolidiorganossiloxanos amido-funcionais
BR0001826B1 (pt) fralda descartÁvel.
IS5129A (is) Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum
IS5130A (is) Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
PT1500654E (pt) Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos
DE60125232D1 (de) Kleines säurelösliches sporenprotein und seine verwendungen
EP1251863A4 (de) 22 sezernierte humane proteine
BR0000706B1 (pt) fralda descartÁvel.
AU2002221908A1 (en) Novel use of protein hydrolysates
BR0001216B1 (pt) fralda descartÁvel.
BR0108056A (pt) Preparados cosméticos com extratos waltheria indica
ATE404602T1 (de) Wässrige polyurethanzubereitungen
BR0209430A (pt) Compostos heterocìclicos
ATE401084T1 (de) Torasemid enthaltende lagerstabile pharmazeutische zubereitungen
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
DE60129123D1 (de) BIOLOGISCH AKTIVE 4H-BENZOi1,4öOXAZIN-3-ONE
PT1200444E (pt) Novos compostos xantona, sua preparacao e sua utilizacao como medicamento
BR0004412B1 (pt) fralda descartÁvel.
ITMI20000293A0 (it) Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica
NO20002242D0 (no) Pustende, absorberende engangsartikkel
PT1150716E (pt) Composicao farmaceutica de proteinas hedgehog hidrofobicamente modificadas e sua utilizacao

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1343896

Country of ref document: EP